Global Liquid Biopsy Market | Growth, Analysis, Trends

1
The Global Liquid Biopsy Market at CAGR of
18.54 by 2028
Triton Market Research presents the Global Liquid
Biopsy Market segmented by Biomarker Type
(Extracellular Vesicles, Nucleic Acid, Cells,
Protein), Therapeutic Application (Prostate
Cancer, Melanoma Cancer, Non-Oncology
Application, Lung Cancer, Colorectal Cancer,
Breast Cancer, Other Types of Cancer), Product
(Circulating Tumor Cells CTCS, Extracellular
Vesicles and Others, Circulating Tumor DNA
CTDNA, Cell-Free DNA CFDNA), Analysis
Platform (PCR, NGS, Proteomics, Microarray, Other
Analysis Platforms), Industry Verticals
(Hospitals, Physicians Office Laboratories,
Clinical Diagnostic Laboratories), Clinical
Application (Treatment Selection, Treatment
Monitoring, Diagnosis and Screening, Prognosis
and Reoccurrence Monitoring), Analysis Purpose
(Therapy Guidance, Monitoring, Early
Detection/Screening, Diagnosis), and Geography
(North America, Latin America, Middle East and
Africa, Asia-Pacific, Europe). The market report
further discusses the Market Summary Industry
Outlook Impact of COVID-19 Key Insights
Porters Five Forces Model Initiatives
Pertaining to Liquid Biopsy Legal, Policy,
Regulatory Framework Market Attractiveness
Index Vendor Scorecard Key Market Strategies
Drivers Restraints Opportunities Competitive
Landscape Research Methodology Scope Global
Market Size Forecasts Analysis
(2021-2028). Tritons report infers that the
global liquid biopsy market is expected to
register growth in revenue by 18.54 of CAGR
during the phase of 2021-2028.
Request a Free Sample https//www.tritonmarketres
earch.com/reports/liquid-biopsy-marketrequest-fre
e-sample
2
Liquid biopsy refers to a non-invasive method
that helps to ascertain and monitor cancer and
other conditions. It is gaining traction as an
alternative to tissue biopsy for application in
reproductive health, cancer, and transplant
medicine. Factors such as advancements in
technologies and growing demand for diagnostics
centers generate new opportunities for the
market over the estimated period. The
ever-changing consumer demand has led to a shift
in diagnostic testing from hospitals to
diagnostics centers, closer to patients. This
lowers the testing cost significantly. Hence,
the rising demand for diagnostics centers can
offer new opportunities to the liquid biopsy
market over the forecast period. However, several
restraints, such as lack of reimbursement for
liquid biopsy, disadvantages associated with
compensation, high cost of liquid biopsy test,
and dearth of skilled professionals, are limiting
the expansion of the liquid biopsy market. The
Asia-Pacific is estimated to attain the fastest
growth rate in the liquid biopsy market over the
considered phase 2021-2028. The countries in the
region are heavily populated, such as China and
India. Thus, the region holds the potential to
offer a huge consumer base, boosting the growth
of the studied market. Furthermore, the increase
in healthcare expenditure, coupled with a rise in
awareness pertaining to liquid biopsy, has
positively impacted the liquid biopsy market in
the regions nations. The enterprises profiled in
the liquid biopsy market include Becton Dickinson
and Company (BD), Thermo Fisher Scientific Inc,
Illumina Inc, Personal Genome Diagnostics,
Bio-Rad Laboratories Inc, Agilent Technologies
Inc, Adaptive Biotechnologies, Biocept Inc,
Menarini-Silicon Biosystems, Foundation
Medicine, Qiagen NV, Myriad Genetics Inc, Natera,
F Hoffmann-La Roche, Guardant Health Inc,
MDxHealth SA, Grail, and Angle Plc. Several
customers generally prefer to opt for popular
products in the market, making it easy for them
to switch from one product to another. This
results in a high competition level among
existing market players. Furthermore, numerous
companies are specializing in several segments,
leading in the market. For instance, Agilent
Technologies specializes in segments such as life
science research, food, and lab automation.
Here, the growth in life science research has
enabled the company to increase its market
share. Contact Us sales_at_tritonmarketresearch.co
m Phone [phone]